Vanguard Portfolio Management »

Vaxcyte shares owned by Vanguard Portfolio Management

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Vanguard Portfolio Management from 13F filings

Historical chart of Vanguard Portfolio Management investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Vanguard Portfolio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Vanguard Portfolio Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $365M 6.3M 58.11

More positions owned by Vanguard Portfolio Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Vanguard Portfolio Management

Top funds holding Vaxcyte

FMR
Vanguard Group
T. Rowe Price Investment Management
RA Capital Management
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Wellington Management Company
State Street Corporation
Paradigm Biocapital Advisors
Deep Track Capital
D. E. Shaw & Co
Westfield Capital Management Company
Kynam Capital Management
Geode Capital Management

View all funds holding Vaxcyte